Nitric oxide/L-arginine in uremia

Mineral and Electrolyte Metabolism

Volumn 25, Issue 4-6, 1999, Pages 384-390

  Aiello, Sistiana ^a   Noris, Marina ^a   Remuzzi, Giuseppe ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Chronic renal failure; Endothelin; Guanidinosuccinate; Nitric oxide; NO synthase

Indexed keywords

ARGININE; ENDOTHELIN; GUANIDINOSUCCINIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; BIOCHEMISTRY; BLEEDING; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; ENZYME DEFICIENCY; GLOMERULOSCLEROSIS; HEMODYNAMICS; HUMAN; KIDNEY FIBROSIS; KIDNEY MASS; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; UREMIA;

EID: 0033367909     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057479     Document Type: Conference Paper

References (67)

1. Moncada S, Higgs EA: Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J 1995;9:1319-1330.
2. Rees DD, Palmer RM, Moncada S: Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA 1989;86:3375-3378.
3. Brockman MJ, Eiroa AM, Marcus AJ: Inhibition of human platelet reactivity by endothelium-derived relaxing factor from human umbilical vein endothelial cells in suspension: Blockade of aggregation and secretion by aspirin-insensitive mechanism. Blood 1991;78: 1033-1040.
4. Sneddon JM, Vane JR: Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells. Proc Natl Acad Sci USA 1988;85:2800-2804.
5. Wang Y, Marsden PA: Nitric oxide synthases: Biochemical and molecular regulation. Curr Opin Nephrol Hypertens 1995;4:12-22.
6. Bachmann S, Mundel P: Nitric oxide in the kidney: Synthesis, localization and function. Am J Kidney Dis 1994;24:112-129.
7. Terada Y, Tomita K, Nonoguchi H, Marumo F: Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest 1992;90:659-665.
8. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA: Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 1994;267:F296-F302.
9. Ito S: Nitric oxide in the kidney. Curr Opin Nephrol Hypertens 1995;4:23-30.
10. Imig JD, Roman RJ: Nitric oxide modulates vascular tone in preglomerular arterioles. Hypertension 1992;19:770-774.
11. Pfeilschifter J, Kunz D, Muhl H: Nitric oxide: An inflammatory mediator of glomerular mesangial cells. Nephron 1993;64:518-525.
12. McLay JS, Chatterjee P, Nicolson AG, Jardine AG, McKay NG, Ralston SH, Grabowski P, Haites NE, MacLeod AM, Hawksworth GM: Nitric oxide production by human proximal tubular cells: A nove immunomodulatory mechanism? Kidney Int 1994;46:1043-1049.
13. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S: Location of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994;45:998-1005.
14. McKee M, Scavone C, Nathanson JA: Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 1994;91:12056-12060.
15. Guzman NJ, Fang M-Z. Tang S-S, Ingelfinger JR, Garg LC: Autocrine inhibition of Na+/ K+ -ATPase by nitric oxide in mouse proximal tubule epithelial cells. J Clin Invest 1995;95: 2083-2088.
16. Anderson S, Meyer TW, Brenner BM: The role of hemodynamic factors in the intiation and progression of renal disease. J Urol 1985;133: 310-315.
17. Remuzzi G, Perico N, Zoja C, Corna D, Macconi D, Viganò G: Role of endothelium-derived nitric oxide in the bleeding tendency of uremia. J Clin Invest 1990;86:1768-1771.
18. Aiello S, Noris M, Todeschini M, Zappella S, Foglieni C, Benigni A, Corna D, Zoja C, Cavallotti D, Remuzzi G: Renal and systemic nitric oxide synthesis in rats with renal mass reduction. Kidney Int 1997;52:171-181.
19. Mitch W, Chesney R: Amino acid metabolism by the kidney. Miner Electrolyte Metab 1983; 9:190-202.
20. Chan W, Wang M, Kopple J, Swendseid M: Citrulline levels and urea cycle enzymes in uremic rats. J Nutr 1974;104:678-683.
21. Boudy N, Hassler C, Parvy P, Bankir L: Renal synthesis of arginine in chronic renal failure: In vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int 1993;44:676-683.
22. Garg U, Hassid A: Inhibition of rat mesangial mitogenesis by nitric oxide-generating vasodilators. Am J Physiol 1989;257:F60-F66.
23. Reyes AA, Purkerson ML, Karl I, Klahr S: Dietary supplementation with L-arginine ameliorates the progression of renal disease in rats with subtotal nephrectomy. Am J Kidney Dis 1992;20:168-176.
24. Ashab I, Peer G, Blum M, Wollman Y, Chernihovsky T, Hassner A, Schwartz D, Caabili S, Silverberger D, Iaina A: Oral administration of L-arginine and captopril in rats prevents chronic renal failure by nitric oxide production. Kidney Int 1995;47:1515-1521.
25. Pitts RF: The effects of infusing glycine and of varying the dietary protein intake on renal hemodynamics in the dog. Am J Physiol 1944; 142:355-377.
26. Castellino P, Coda B, DeFronzo RA: The effects of amino acids infusion on renal hemodynamics in humans. Am J Physiol 1986;251:F132-F140.
27. Benigni A, Zoja C, Noris M, Corna D, Benedetti G, Bruzzi I, Todeschini M, Remuzzi G: Renoprotection by nitric oxide donor and lisinopril in the remnant kidney model. Am J Kidney Dis 1999; 33:746-753.
28. Floege J, Burns MW, Alpers CE, Yoshimura A, Pritzl P, Gordon K, Seifert RA, Bowen-Pope DF, Couser WG, Johnson RJ: Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992;41:297-309.
29. Lee LK, Meyer TW, Pollock AS, Lovett DH: Endothelial cell injury initiates glomerular sclerosis in the rat remnant kidney. J Clin Invest 1995;96:953-964.
30. Ketteler M, Border WA, Noble NA: Cytokines and L-arginine in renal injury and repair. Am J Physiol 1994;267:F197-F207.
31. Beck K-F, Mohaupt MG, Sterzel RB: Endothelin-1 inhibits cytokine-stimulated transcription of inducible nitric oxide synthase in glomerular mcsangial cells. Kidney Int 1995;48: 1893-1899.
32. Markewitz BA, Michael JR, Kohan DE: Endothelin-1 inhibits the expression of inducible nitric oxide synthase. Am J Physiol 1997;272: L1078-L1083.
33. Sakamoto H, Sasaki S, Hirata Y, Imai T, Ando K, Ida T, Sakurai T, Yanagisawa M, Masaki T, Marumo F: Production of endothelin-1 by rat cultured mcsangial cells. Biochem Biophys Res Commun 1990;169:462-468.
34. Stewart DJ, Cybulsky AV: Glomerular epithelial cells produce endothelin-1 (abstract). J Am Soc Nephrol 1991:2:417A.
35. Kohan DE: Endothelin synthesis by rat tubule cells. Am J Physiol 1991;261:F221-F226.
36. Orisio S, Benigni A, Bruzzi I, Corna D, Perico N, Zoja C, Benatti L, Remuzzi G: Renal endothelin gene expression is increased in remnant kidney and correlates with disease progression. Kidney Int 1993;43:354-358.
37. Bruzzi I, Corna D, Zoja C, Orisio S, Shiffrin EL, Cavallotti D, Remuzzi G, Benigni A: Time course and localization of endothelin-1 gene expression in a model of renal disease progression. Am J Pathol 1997;151:1241-1247.
38. Benigni A, Zoja C, Corna D, Orisio S, Longaretti L, Bertani T, Remuzzi G: A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression. Kidney Int 1993;44:440-444.
39. Remuzzi G: Bleeding in renal failure. Lancet 1988;1:1205-1208.
40. Joly GA, Schini VB, Vanhoutte PM: Ballon injury and interleukin-1β induce nitric oxide synthase activity in rat carotid arteries. Circ Res 1992;71:331-338.
41. Brashers VL, Peach MJ, Rose CE: Augmentation of hypoxic pulmonary vasoconstriction in the isolated perfused rat lung by in vitro antagonists of endothelium-dependent relaxation. J Clin Invest 1988;82:1495-1502.
42. Radomski MW, Vallance P, Whitley G, Foxwell N, Moncada S: Platelet adhesion to human vascular endothelium is modulated by constitutive and cytokine induced nitric oxide. Cardiovasc Res 1993;27:1380-1382.
43. Radomski MW, Palmer RMJ, Moncada S: An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.
44. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, Figliuzzi M, Remuzzi G: Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993;44:445-450.
45. Hogman M, Frostell C. Arnberg H, Hedenstierna G: Bleeding time prolongation and NO inhalation. Lancet 1993;341:1664-1665.
46. Noris M, Morigi M, Donadelli R, Aiello S, Foppolo M, Todeschini M, Orisio S, Remuzzi G, Remuzzi A: Nitric oxide synthesis by cultured endothelial cells is modulated by flow conditions. Circ Res 1995;76:536-543.
47. Awolesi MA, Sessa WC, Sumpio BE: Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 1995;96:1449-1454.
48. Noris M, Todeschini M, Zappella S, Zoja C, Corna D, Gaspari F, Remuzzi G: 17β-Estradiol fully corrects abnormal primary hemostasis in experimental uremia by effectively limiting vascular endothelial overexpression of nitric oxide forming enzymes. (Submitted) 1998.
49. Zoja C, Noris M, Corna D, Viganò G. Perico N, De Gaetano G, Remuzzi G: L-arginine, the precursor of nitric oxide, abolishes the effect of estrogens on bleeding time in experimental uremia. Lab Invest 1991;65:479-483.
50. Madore F, Prud'homme L, Austin JS, Blaise G, Francoeur M, Léveillé M, Prud'homme M, Vinay P: Impact of nitric oxide on blood pressure in hemodialysis patients. Am J Kidney Dis 1997;30:66f5-671.
51. Matsumoto A, Hirata Y, Kakoki M, Nagata D, Momomura S-I, Sugimoto T, Tagawa H, Omata M: Increased excretion of nitric oxide in exhaled air of patients with chronic renal failure. Clin Science 1998 (in press).
52. Thuraisingham RC, Cramp HA, McMahon AC, et al: Increased superoxide and nitric oxide production results in peroxynitrite formation in uremic vasculature (abstract). J Am Soc Nephrol 1997;8:340A.
53. Nathan C, Xie Q-W: Nitric oxide synthases: Roles, tolls and controls. Cell 1994;78:915-918.
54. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jumgers P, Dayer J-M: Balance between IL-1β. TNF-α and their specific inhibitors in chronic renal failure and maintenance dialysis. J Immunol 1995;154:882-892.
55. Herbelin A, Nguyen AT, Zingraff J, Urena P, Descamps-Latscha B: Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor α. Kidney Int 1990;37: 116-125.
56. Noris M, Todeschini M, Casiraghi F, Roccatello D, Martina G, Minetti L, Imberti B, Gaspari F, Atti M, Remuzzi G: Effect of acetate, bicarbonate dialysis and acetate-free biofiltration on nitric oxide synthesis: Implications for dialysis hypotension. Am J Kidney Dis 1998;32:115-124.
57. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA: Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 1988;33:29-35.
58. Yokokawa K, Kohno M, Yoshikawa J: Nitric-oxide mediates the cardiovascular instability of haemodialysis patients. Curr Opin Nephrol Hypertens 1996;5:359-363.
59. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, Kano H, Horio T, Takeda T, Mandel AK: Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Intern Med 1995;123:35-37.
60. Rysz J, Luciak M, Kedziora J, Blaszczyk J, Sibinska E: Nitric oxide release in the peripheral blood during hemodialysis. Kidney Int 1997;51: 294-300.
61. Thomas G, Ramwell PW: Endothelium-derived relaxing factor and the vascular role of guanidino compounds. Transplant Proc 1993;25:2057-2060.
62. Horowitz HI, Bronx NY: Uremic toxins and platelet function. Arch Intern Med 1970;126: 823-826.
63. Horowitz HI, Stein IM, Cohen BD, White JG: Further studies on the platelet-inhibitory effect of guanidinosuccinic acid and its role in uremic bleeding. Am J Med 1970;49:336-345.
64. Levillain O, Marescau B, de Deyn PP: Guanidino compound metabolism in rat subjected to 20% to 90% nephrectomy. Kidney Int 1995;47: 464-472.
65. Thomas G, Ramwell PW: Identification of guanidino succinate as a putative endogenous source of the endothelium derived relaxing factor. Biochem Biophys Res Commun 1992;183:584-589.
66. Todeschini M, Noris M, Gaspari F, Imberti B, Remuzzi G: Guanidino succinate stimulates the release of nitric oxide (NO) from cultured endothelial cells: Possible implications for uremic bleeding. J Am Soc Nephrol 1998 (in press).
67. Stein IM, Cohen BD, Horowitz HI: Guanidino-succinic acid: The 'X' factor in uremic bleeding? (abstract). Clin Res 1968;16:397.